Australia markets close in 1 hour 29 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.34+0.07 (+0.17%)
At close: 04:00PM EDT
42.29 -0.05 (-0.12%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-6,148,000
8,025,000
6,327,000
6,994,000
-9,015,000
-
Depreciation & amortisation
9,863,000
9,760,000
10,276,000
10,686,000
10,380,000
-
Deferred income taxes
-3,451,000
-3,288,000
-2,738,000
-1,393,000
983,000
-
Stock-based compensation
529,000
518,000
457,000
583,000
779,000
-
Change in working capital
-356,000
-1,914,000
-2,229,000
-1,261,000
983,000
-
Inventory
-687,000
-751,000
-69,000
13,000
2,672,000
-
Accounts payable
311,000
198,000
109,000
245,000
188,000
-
Other working capital
12,509,000
12,651,000
11,948,000
15,234,000
13,299,000
-
Other non-cash items
14,105,000
1,213,000
1,038,000
800,000
9,504,000
-
Net cash provided by operating activities
13,724,000
13,860,000
13,066,000
16,207,000
14,052,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,215,000
-1,209,000
-1,118,000
-973,000
-753,000
-
Acquisitions, net
-21,144,000
-1,169,000
-4,286,000
-1,610,000
-13,084,000
-
Purchases of investments
-1,848,000
-1,774,000
-3,592,000
-5,478,000
-4,172,000
-
Sales/maturities of investments
1,581,000
948,000
6,629,000
6,775,000
6,409,000
-
Net cash used for investing activities
-21,703,000
-2,295,000
-1,062,000
-538,000
-10,859,000
-
Cash flows from financing activities
Debt repayment
-2,239,000
-3,879,000
-11,431,000
-6,022,000
-2,750,000
-
Common stock repurchased
-4,905,000
-5,155,000
-8,001,000
-6,287,000
-1,546,000
-
Dividends paid
-4,760,000
-4,744,000
-4,634,000
-4,396,000
-4,075,000
-
Other financing activities
-
-
-
641,000
542,000
-53,000
Net cash used provided by (used for) financing activities
8,278,000
-9,416,000
-16,962,000
-16,224,000
-1,151,000
-
Net change in cash
286,000
2,194,000
-4,991,000
-657,000
2,153,000
-
Cash at beginning of period
9,048,000
9,325,000
14,316,000
14,973,000
12,820,000
-
Cash at end of period
9,347,000
11,519,000
9,325,000
14,316,000
14,973,000
-
Free cash flow
Operating cash flow
13,724,000
13,860,000
13,066,000
16,207,000
14,052,000
-
Capital expenditure
-1,215,000
-1,209,000
-1,118,000
-973,000
-753,000
-
Free cash flow
12,509,000
12,651,000
11,948,000
15,234,000
13,299,000
-